rs886037674
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_177438.3(DICER1):c.1684_1685delAT(p.Met562ValfsTer11) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_177438.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
DICER1-related tumor predisposition Pathogenic:3
ACMG criteria met: PVS1, PM2, PM7, PP4 -
- -
Loss-of-function variants in DICER1 are known to be pathogenic (PMID: 19556464, 21266384). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has been observed in several individuals affected with pleuropulmonary blastoma (PMID: 19556464, 26925222). ClinVar contains an entry for this variant (Variation ID: 254290). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Met562Valfs*11) in the DICER1 gene. It is expected to result in an absent or disrupted protein product. For these reasons, this variant has been classified as Pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1684_1685delAT pathogenic mutation, located in coding exon 9 of the DICER1 gene, results from a deletion of two nucleotides at nucleotide positions 1684 to 1685, causing a translational frameshift with a predicted alternate stop codon (p.M562Vfs*11). This mutation has been reported in multiple patients with pleuropulmonary blastoma (Hill DA et al. Science, 2009 Aug;325:965; Brenneman M et al. F1000Res, 2015 Jul;4:214). Of note, this alteration is also referred to as 1866-1867delAT in the literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at